Big pharma for a new deal on applications in Japan,(RA,Renal complications,Cronhs,Lower Back Pain) and maybe even CHF because as the Prof stated applications can go to market in Japan after phase 2 trials.The other option is for more applications for Teva or Celenge!
Big pharma for a new deal on applications in Japan,(RA,Renal...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.38 |
Change
-0.075(5.15%) |
Mkt cap ! $1.587B | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.43 | $1.37 | $5.036M | 3.622M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1716 | $1.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 2067 | 3 |
View Market Depth
| Last trade - 15.59pm 16/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |